Tumor Pathology





Tumor Pathology


Tumor Pathology

Tumor Pathology

Concept:

  • Tumor is a neoplastic mass caused by abnormal, excessive, and autonomous proliferation of transformed body cells.
  • Tumor is cell proliferation triggered by mutations (MUT).
  • MUT causing the disease gives tumor cells the ability to survive, grow, and proliferate vigorously independently of normal physiological signals (autonomous proliferation).

Distinguish between tumor and pseudotumor:

  • Pseudotumor is a lesion that does not have the ability to proliferate autonomously.
  • Examples of pseudotumor (pseudo-tumor lesions):
  • Nasal polyp
  • Thyroid goiter
  • Harmatoma in the lungs
  • Choristom (ectopic pancreatic tissue in the stomach)

Tumor classification:

  • Benign tumor:
  • Slow growth
  • Localized, does not spread to other areas
  • Completely recovered after surgery, rarely fatal
  • Example: Meningioma can be fatal.
  • Malignant tumor:
  • Fast growth
  • Invade the surrounding area, distant metastasis
  • Usually fatal
  • Example: Basal cell carcinoma of the skin is rarely fatal.
  • Borderline malignant tumor:
  • Degree of malignancy is unclear, unpredictable progression
  • Slow progression
  • Invade the surrounding area, rarely distant metastasis
  • Often recurs after excision

Tumor components:

  • Two basic tumor components:
  • Tumor parenchyma: Tumor cells, the component that determines the name of the tumor.
  • Tumor stroma: Connective tissue, blood vessels, lymph, supporting the tumor parenchyma and nourishing the tumor cells.
  • One type of tumor that does not have a stroma: Leukemia (blood cancer).

Tumor nomenclature:

  • Benign tumor from mesenchyme: Cell type name + oma
  • Fibroma: Fibrous tumor
  • Lipoma: Fatty tumor
  • Chondroma: Cartilage tumor
  • Osteoma: Bone tumor
  • Hemangioma: Blood vessel tumor
  • Lymphangioma: Lymph vessel tumor
  • Leiomyoma: Smooth muscle tumor
  • Rhabdomyoma: Striated muscle tumor
  • Benign tumor from epithelium: Cell type name + oma
  • Adenoma: Glandular tumor
  • Cystadenoma: Cystic glandular tumor
  • Papilloma: Papillary tumor
  • Squamous papilloma: Skin papilloma
  • Malignant tumor from mesenchyme: Cell type name + sarcoma
  • Fibrosarcoma: Fibrous sarcoma
  • Liposarcoma: Fatty sarcoma
  • Chondrosarcoma: Cartilage sarcoma
  • Osteosarcoma: Bone sarcoma
  • Hemagiosarcoma: Blood vessel sarcoma
  • Lymphangiosarcoma: Lymph vessel sarcoma
  • Leiomyosarcoma: Smooth muscle sarcoma
  • Rhabdomyosarcom: Striated muscle sarcoma
  • Malignant tumor from epithelium: Cell type name + carcinoma
  • Adenocarcinoma: Glandular carcinoma
  • Cystandenocarcinoma: Cystic glandular carcinoma
  • Squamous cell carcinoma: Squamous cell carcinoma
  • Basal cell carcinoma: Basal cell carcinoma
  • Urothelial carcinoma: Urothelial carcinoma
  • Hepatocellular carcinoma: Hepatocellular carcinoma
  • Other types of tumors:
  • Pleomorphic adenoma, mixed tumor: Pleomorphic adenoma
  • Teratoma: Germ cell tumor (benign/malignant/borderline malignant)
  • Melanoma: Melanoma
  • Lymphoma: Lymphoma
  • Ewing’s sarcoma, Wilms’ tumor: (no detailed description)
  • Fibroadenoma: Benign fibroadenoma
  • Adenofibroma: Benign glandular fibrous tumor
  • Adenomyoma: Benign glandular smooth muscle tumor
  • Adenosarcoma: Tumor with benign epithelial and malignant mesenchymal components
  • Carcinosarcoma: Tumor with malignant epithelial and mesenchymal components
  • Seminoma, Dysgerminoma, Yolk sac tumor: Malignant germ cell tumors
  • Seminoma: Seminoma in the testis
  • Dysgerminoma: Dysgerminoma in the ovary
  • Yolk sac tumor: Yolk sac tumor

Gross observation:

  • Need to describe:
  • Shape
  • Size
  • Boundaries
  • Capsule
  • Density
  • Cut surface
  • Some common gross forms of benign tumors:
  • Protrusion
  • Polyp
  • Papillary
  • Some common gross forms of malignant tumors:
  • Exophytic mass
  • Ulcer
  • Hard infiltration
  • Gross description of benign tumor:
  • Well-defined boundaries, encapsulated, small size, slow growth, homogenous cut surface, firm density.
  • Gross description of malignant tumor:
  • No clear boundaries, infiltrating surrounding tissue, no capsule, large size, fast growth, heterogeneous cut surface with many areas of necrosis and hemorrhage, soft density.

Microscopic observation:

  • Microscopic description of benign tumor:
  • Well-differentiated in terms of structure and function (similar to normal tissue of origin)
  • Mitotic figures +/-
  • No invasion of surrounding tissue
  • Microscopic description of malignant tumor:
  • Decreased differentiation in structure and function
  • Invasion of surrounding tissue
  • Decreased differentiation includes:
  • Increased cell density, disordered orientation
  • Cellular and nuclear pleomorphism
  • Hyperchromatic nuclei, deformed nuclei, large nucleoli, increased N/C ratio
  • Increased mitotic figures, abnormal mitotic figures
  • Cytoplasm containing normal or abnormal products
  • Signs of malignancy: Abnormal mitotic figures

Histologic grading:

  • Purpose: Assess the degree of malignancy
  • Based on: Degree of differentiation, degree of atypia, necrosis, mitotic index

Natural progression of cancer:

  • Four stages:
  • Malignant transformation (monoclonal)
  • Tumor growth
  • Local invasion
  • Metastasis

Difference between tumor cells and cells of reactive hyperplastic tissue:

  • Tumor cells: Arising from a single initial cell => monoclonal.
  • Cells of reactive hyperplastic tissue: Originating from many different cells => polyclonal.

Role of determining monoclonal nature:

  • Distinguish between hyperplastic lymph nodes and tumors.

Hayflick limit:

  • The limit on the number of divisions of normal cells, corresponding to cell aging.
  • Tumor cells are not affected by the Hayflick limit.
  • Tumor cells are immortal due to their ability to regenerate lost telomere segments through the activity of telomerase.

Note:

  • The article has been rewritten from the given data, but it may still be incomplete or inaccurate.
  • Consult additional specialized literature for a more comprehensive view of tumor pathology.



Leave a Reply

Your email address will not be published. Required fields are marked *